Competition and substitutability in the Swedish pharmaceuticals market

Substitution possibilities between brand name pharmaceuticals are analysed. The analysis is based on data from three different markets; the prescription drug market for beta-blocking agents, the 'over the counter' market for purgatives and the hospital market for two pharmaceutical treatments for gastric ulcers. The results indicate that there exist some substitution possibilities among the brand name drugs included in the study.